Ralf Kuriyel, Senior VP, R&D at REPLIGEN CORP (RGEN), sold 14,121 shares at $159.36 ($2.3M) on 2024-08-02, disclosed to the SEC on 2024-08-05.
Open-market sale of $2.3M RGEN by Senior VP, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.85 | 175 | $28K | 1.2% |
| 2 | $159.36 | 6,973 | $1.1M | 49.4% |
| 3 | $159.36 | 6,973 | $1.1M | 49.4% |
| Total | $159.35 avg | 14,121 | $2.3M | 100% |
| Filing → |
| RGEN | SELL | 2022-08-12 | $2.3M | — | Filing → |
| RGEN | SELL | 2021-09-02 | $2.3M | — | Filing → |
| RGEN | SELL | 2021-06-14 | $2.6M | — | Filing → |